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Summary The present article summarizes the characteristics of a synthetic octacalcium
phosphate (OCP) and OCP-based materials. We previously established a method for a relatively
large scale synthesis of OCP and showed that OCP enhances bone regeneration more than
hydroxyapatite (HA) materials, including HA obtained through hydrolysis of OCP, coupled with
material biodegradation if implanted in various bone defects. One of the OCP-based materials
consisting of OCP and natural polymers, such as gelatin, induced a bone regeneration rate over
70% in critical sized rat calvaria defects, which approached the rate seen with autologous bone
implantation. The bone regenerative properties observed for OCP-based materials could be due
to the biological activity of OCP crystals that enhance in vitro osteoblast differentiation and
osteoclast formation from precursor cells. OCP controls the environment around its own crystals,
where osteoblastic cells encounter OCP during the progressive conversion to HA under physio-
logical conditions. This process contributes to an increase in the biological activity of OCP,
resulting in enhancing bone regeneration. Although the positive effect of OCP depends on the
crystal stoichiometry and morphology, determined by the conditions used preparing OCP, it is
probable that OCP-based materials could be good candidates for an advanced material compati-
ble to autologous bone.
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OCP-based bone substitute materials 591. Introduction
Autologous bone is recognized as the most osteoconductive
and osteoinductive bone substitute material available for
implantation in bone defects [1]. These observed properties
of autologous bone are due to the presence of osteoblastic
cells and growth factors, such as bone morphogenetic pro-
teins (BMP), and matrix materials, such as collagen and
hydroxyapatite (HA) crystals. However, in order to overcome
the limitations of the availability of autologous bone and
prevent the unnecessary pain of a second surgery in patients,
synthetic biocompatible materials have widely been devel-
oped and used as alternatives for autologous bone to repair
bone defects [2—9]. Calcium phosphate ceramic materials,
such as sintered HA and b-tricalcium phosphate (b-TCP),
have been extensively studied and clinically applied
[3,7,10]. Sintered HA is classified as a relatively stable
material chemically and has been shown to remain undis-
solved in bone defects over a long period of time, but
provides better biocompatibility with the regenerative tissue
[2,5,11]. In contrast, b-TCP is a resorbable material if
implanted in bone defects [12,13], due to the intrinsic
solubility at physiological pH [14], although the dissolution
of this material is followed by an osteoclastic cellular pha-
gocytotic response [13].
Recently, the property of resorbable materials in vivo has
attracted the interest of material scientists and researchers
in the field of tissue engineering. Such materials biodegrade
and can be substituted by new bone over time through the
process of bone remodeling [15]. The materials are chemi-
cally resorbable under physiological conditions, and the
increased space made by the material dissolution is replaced
with new bone formation [7,13,16]. This is advantageous for
repairing bone defects; however, the biological response of
cells to this type of material can be regarded as passive,
although some materials, such as b-TCP, are not only dis-
solved through simple chemical dissolution, but also resorbed
by osteoclastic cells [13,14]. The purpose of this review
article is to describe the characteristics of octacalcium
phosphate (OCP) and OCP-based composite materials, which
were experimentally characterized in the laboratory. OCP
materials are of biological interest because the materials
themselves have a positive effect on bone forming cellssimilar to autologous bone. OCP has been postulated as a
precursor of biological apatite crystals in bone as well as
tooth dentin and enamel [17,18]. The osteoconductivity of
synthetic OCP was first described through implantation onto
mouse calvaria [19]. Recently, studies using synthetic OCP
have intensified in order to elucidate the bone regenerative
properties and establish an approach for using it in various
bone defects [20—31].
2. Biodegradable calcium phosphate and
OCP
2.1. Biodegradable calcium phosphates
Calcium phosphate ceramics that have been reported to
biodegrade in vivo are summarized in Table 1. Acidic calcium
phosphates, such as dicalcium phosphate anhydrous (DCPA)
and OCP, are classified as soluble ceramics at neutral pH
[4,14]. a-TCP [4,32] and amorphous calcium phosphate (ACP)
[33—35] are recognized as highly soluble materials at neutral
pH and have also been shown to biodegrade [32,36]. The
biodegradability in vivo is in general considered to be asso-
ciated with the solubility of calcium phosphate at physiolo-
gical pH [4,14]. In addition, b-TCP is widely recognized as a
biodegradable ceramic in vivo [7,13] although this material
has been shown to start to dissolve in an experimental
solution with a pH less than 6.0 [37]. Histological findings
have revealed that some calcium phosphate ceramics can be
resorbed by osteoclastic cells [8,13,23,25,38—41], including
biphasic calcium phosphate (BCP) [40,41], which consists of
two phases of HA and b-TCP, as well as carbonate-containing
HA (carbonate HA) [8,42,43] and nano-HA [39]. HA is most
stable chemically at physiological pH. However, the stability
decreases as the non-stoichiometry increases [7], displaying
Ca-deficiency and the presence of impurities, such as carbo-
nate [44], in the structure. A decrease in the size of the
crystals to a nanoscale level usually increases its dissolution
and induces changes in the physicochemical properties, such
as changes in the crystallinity [45]. The structure of OCP is
stacked alternatively with hydrated layers [18]. Based on this
structure, OCP has been proposed to be a precursor of
biological apatite crystals in bone and tooth [17,18]. As
shown in Table 1, the chemical formula of OCP is
Table 1 Calcium phosphate ceramics reported to show biodegradation in vivo after a single use.
Calcium phosphates Abbreviation Chemical
formula
Ca/P molar ratio
(theoretical)
In vivo condition reported
Implant form Osteoclastic
resorption
Dicalcium phosphate
anhydrous
DCPA CaHPO4 1.0 Powdery [19] Not examined
Octacalcium phosphate OCP Ca8H2(PO4)65H2O 1.33 Granules
[19,24,27,29]
Resorbed
a-Tricalcium phosphate a-TCP Ca3(PO4)2 1.5 Block [32] Not reported
b-Tricalcium phosphate b-TCP Ca3(PO4)2 1.5 Granules [7,13]/
block [12]
Resorbed
Amorphous calcium
phosphate
ACP Ca3(PO4)2nH2O 1.5 Coating [36]/
granules [19]
Not reported
Biphasic calcium
phosphate
BCP HA and b-TCP
(in phase)
Dependent on ratio
of HA and b-TCP
Granules [40,41] Resorbed
Carbonate-containing
hydroxyapatite
Carbonate
HA
Ca10(PO4, CO3)6(OH)2 Non-stoichiometric Block [6]/deposit
with polymers [8]
Resorbed
Nano-hydroxyapatite Nano-HA Ca10(PO4)6(OH)2 If stoichiometric: 1.67 Deposit with
polymers [39]
Resorbed
60 O. SuzukiCa8H2(PO4)65H2O, which has a theoretical Ca/P molar ratio
of 1.33. Interestingly, OCP exhibits variation in stoichiometry,
and consequently, the Ca/P molar ratios vary from 1.23 to
1.37 [30,46—48]. These OCPs exhibit remarkable differences
in osteoconductivity [46], which may be due to the physico-
chemical changes that occur in the synthesis conditions [49].
It has been proposed that the non-stoichiometric OCP struc-
ture has excess hydrogen, resulting in a non-stoichiometric
chemical formula, Ca16H4+x(PO4)12(OH)x(10  x)H2O, which
resembles the structure of HA even more closely than pre-
viously anticipated [50]. The preparation conditions may be
critical for producing diversity in the chemical and physical
properties of OCP, because OCP crystals exhibit plate-like
morphologies with wide variation in their dimension [48,51—
54]. Together, these findings demonstrate the remarkable
differences in crystal size and direction of growth toward a
particular axis, depending on the preparation conditions.
2.2. Chemical properties of OCP in medium
The solubility of calcium phosphates can be estimated by
measuring the degree of supersaturation (DS) with respect
to particular calcium phosphate phases [55—57]. Table 2
shows the DS values in the supernatant after soaking dical-
cium phosphate dihydrate (DCPD), OCP, b-TCP, and HA inTable 2 Degree of supersaturation of alpha essential minimal med
at 37 8C.
Calcium phosphates Degree of supersatu
HA 
DCPD 4.9  108
OCP 3.2  1010
b-TCP 1.4  1012
HA 5.6  1011
a-MEM 8.8  1011
Reproduced from Morimoto et al. [58] with permission from IOP Publishingalpha essential minimal medium (a-MEM) for 72 h at 37 8C,
as previously reported [58]. The DS can be expressed by
dividing the ionic product by the solubility product from the
objective calcium phosphate [55—57]. The DS is usually
calculated using the analytical results, including the con-
centration of calcium (Ca2+) and inorganic phosphate (Pi)
ions as well as the pH of the solution [55—57,59]. The results
showed that a-MEM was supersaturated with HA and OCP
before the introduction of calcium phosphate materials,
but undersaturated with DCPD, suggesting that a-MEM has
the potential to form HA and OCP if seeded with crystals.
The composition of a-MEM after the introduction of DCPD
became saturated with respect to DCPD, and the introduc-
tion of OCP induced a slight supersaturated condition. In
addition, the introduction of b-TCP and HA induced a
relatively higher supersaturated condition with respect
to OCP and HA. In particular, b-TCP induced a supersatu-
rated condition that was higher than that of the a-MEM
alone. Thus, calcium phosphates seeded in a-MEM may be
deposited with newly formed HA and possibly OCP [58],
although the crystal growth may also be affected by the
kinetics of the specific calcium phosphate phase associated
with the inhibitory effect of some of the ionic regulators,
such as small amounts of magnesium and other factors
[55,60—63].ium (a-MEM) after soaking calcium phosphate ceramics for 72 h
ration
OCP DCPD
1.8  103 6.7
7.5  101 2.1  101
8.6  102 3.0  101
5.5  102 3.0  101
2.7  103 7.5  101
 Ltd.
Figure 1 Undecalcified, hematoxylin and eosin (H&E) stained
histological section of an OCP granule having a 500—1000 mm
diameter, implanted in the intramedullary canal of a rabbit
femur at 4 weeks. Aligned cuboidal osteoblasts formed bone
matrix (non-calcified osteoid bone matrix) around the OCP
granule. Calcified bone matrix underneath the osteoid tissue
can be observed because of the use of the undecalcified tissue.
Osteoclasts (arrow and double arrows) were resorbing directly on
the surface of the OCP granule. An osteoclast (arrow) was in
direct contact with two osteoblasts, indicating a close associa-
tion and coupling between osteoblasts and osteoclasts. The
details of the experiments have been reported in Imaizumi
et al. [23]. Asterisk: OCP; B: newly formed bone. Bar = 100 mm.
All procedures in the experiment were approved by the Animal
Research Committee of Tohoku University.
OCP-based bone substitute materials 613. Bone substitute materials showing
possibly biologically active properties
It is of great interest to determine whether calcium phosphate
ceramics positively promote osteogenesis, because recent
studies have shown that some calcium phosphate ceramics
have osteoinductive properties [64—66], including the capabil-
ity to induce ectopic bone formation. It seems likely that the
osteoinductive properties are due to the geometry of the
materials and the surface nanostructure, which provides a site
for osteoblastic cell attachment, migration, grow, and differ-
entiation to form bone matrix [64—69], resulting in the onset of
bone mineralization. In contrast, although such structural
effects may be essential for the regeneration of new bone,
the mechanism by which calcium phosphate materials them-
selves affect a biological response after implantation into bone
defects has not been elucidated. Some studies have explored
the effect of calcium phosphate materials on osteoblastic cells
in vitro. HA ceramic particles ranging from submicron size to
approximately 800 mm in diameter can influence the biological
response of fibroblasts and myoblasts [70]. Calcium phosphate
particles with various Ca/P molar ratios and in the nano- and
micrometer ranges in size also have an influence on osteoblas-
tic differentiation [71]. The b-TCP granules provide a scaffold
for osteoblast colony formation over time on their surfaces
[72]. This material also controls signaling of human osteoblasts,
as increased a2 integrin subunit gene expression and activation
of the mitogen-activated protein kinase (MAPK)/extracellular
related kinase (ERK) signaling pathway has been observed [73].
These findings suggest that some calcium phosphates positively
affect cellular function with regard to tissue generation; how-
ever, these studies have not shown the direct effects of calcium
phosphate, and therefore we cannot exclude the possibility
that the geometry affects cellular function. Therefore, further
studies are needed to compare morphology, chemical composi-
tion, dose, and other parameters of the materials in order to
fully elucidate these mechanisms.
4. Bone regenerative properties of OCP
4.1. Characteristics of bone formation induced
by OCP implantation
Several lines of evidence have confirmed that OCP is an
osteoconductive material that enhances bone regeneration
in regions adjacent to the implanted OCP if used as a filling
material in bone defects of various animal models [23—
25,29,30,74]. One of the remarkable characteristics of
OCP in bone regeneration is that osteoblasts aligned on an
OCP implant initiate new bone deposition from a structure
consisting of OCP particles and non-collagenous proteins, the
latter of which originates from surrounding circulating serum
proteins [19,75]. Interestingly, the initial bone matrix formed
around OCP was shown to consist of fine filaments and small
granular materials within the non-collagenous matrix at the
ultrastructural level [19]. The structure was almost identical
to the components of bone nodules previously described by
Bernard and Pease [76], and considered to be a site that
initiates intramembranous bone development [76—79].
Therefore, it is probable that OCP implantation into bonetissue may emulate the onset of bone formation, at least
regarding the morphological features of the initial bone
deposition [19]. This initial step is followed by additional
bone formation, which is characterized by collagen forma-
tion and accompanied by apatite crystal deposition [79,80],
namely, the progress of bone mineralization.
4.2. Osteoblastic and osteoclastic cells observed
around OCP
Fig. 1 shows a typical in vivo cellular response induced by OCP
implantation into a bone defect [23], showing new bone
formation by osteoblasts and OCP biodegradation through
the direct resorption of osteoclast-like cells. This figure is a
histological section of an OCP granule implanted for 4 weeks
intramedullary in a 3 mm diameter defect created in the
cortex of the femoral metaphysic of a rabbit femur using
undecalcified specimen stained with hematoxylin and eosin
(H&E). The OCP granules used were 500—1000 mm in dia-
meter. Osteoblasts were directly aligned on the OCP granule
surface as well as on the newly formed osteoid bone matrix.
Osteoblasts were cuboidal in shape, indicating that active
synthesis of bone matrix collagen was occurring. In addition,
osteoclast-like multinuclear giant cells were present
between cuboidal osteoblasts, which were on the bone
matrix deposited onto the OCP surface. An osteoclast-like
cell was in contact with the two osteoblasts and attached
directly to the OCP surface for resorption (Fig. 1, upper
section, arrow). Osteoclast-like cells also resorbed the
Figure 2 Undecalcified, H&E stained histological section of OCP
granules, having a 500—1000 mm diameter and implanted in the
intramedullary canal of rabbit femur at 2 weeks. The OCP granules
were surrounded by cancellous bone near repaired cortical bone.
The details of the experiments have been reported in Imaizumi et al.
[23]. Asterisk: OCP; B: newly formed bone. Bar = 500 mm. All pro-
cedures in the experiment were approved by the Animal Research
Committee of Tohoku University.
62 O. SuzukiOCP surface (Fig. 1; upper section, double arrow) and inter-
faced between the OCP and new bone (Fig. 1, lower section,
double arrow). These multinuclear osteoclast-like cells were
confirmed to be TRAP-positive cells [23]. Moreover, the bone
formation induced by OCP implantation not only occurs at the
margins of the bone defect, but also frequently initiates
directly from the OCP surface [19,24,30,75]. Biodegradation
by direct resorption of osteoclast-like cells has been mostly
observed in OCP implantations examined through various
animal bone defect models, such as mouse and rat calvarias
as well as rat and rabbit femurs [23,25,38,46,81,82]. Thus,
OCP is recognized as a biodegradable material that promotes
simultaneous bone formation by osteoblasts.
4.3. Distinctive features of bone formation by
OCP implantation
Fig. 2 shows an undecalcified histological section of OCP
granules surrounded by cancellous bone that were formed
in the bone marrow space of a rabbit femur at 2 weeks post-
implantation. The experimental model was the same as that
shown in Fig. 1. Some of the OCP granules were encapsulated
with new bone that had grown from cortical bone or cancel-
lous bone in the bone marrow space. As described above,
although osteoclast-like cells were able to biodegrade OCP,
most of the OCP granules were still present at this stage. The
rate of degradation of the granules is a function of the
granule size [82,83]. The number of TRAP-positive osteo-
clast-like cells increased as the OCP granule size increased
from 53—300 and 300—500 to 500—1000 mm in diameter if
implanted in mouse critical-sized calvaria defects [82]. This
tendency was associated with the amount of bone regenera-
tion that occurred around OCP granules [82]. However, the
bone regeneration occurring on a material OCP/collagen
composite was enhanced as the granule size decreased in
the presence of TRAP-positive cells [83]. The TRAP activity
around OCP granules was much higher than that of HA
granules when implanted onto mouse calvaria, while the
amount of bone formation around the granules was muchFigure 3 Undecalcified, H&E stained histological section of OCP granules having a 500—1000 mm diameter, implanted in the
intramedullary canal of a rabbit femur at 12 weeks (a and b). The OCP granules were almost resorbed in the bone marrow space (a). The
debris from OCP granules were embedded in the repaired cortical bone (b). The details of the experiments have been reported in
Imaizumi et al. [23]. Asterisk: OCP; B: newly formed bone. Bars = 2 mm (a) and 200 mm (b). Figure (b) is a magnified view of (a) marked
by the rectangle. All procedures in the experiment were approved by the Animal Research Committee of Tohoku University.
Figure 4 Observation of osteoclastic cells on OCP-coated
plates. Co-cultures of mouse bone marrow cells and osteoblastic
cells with OCP (a) and without OCP (control experiment) (b) for 6
days, showing formation of TRAP-positive osteoclastic cells
(arrows) only if incubated with OCP (a). These co-cultures were
grown in the absence of 1,25(OH)2D3, which is an essential factor
for up-regulating RANKL. Mature osteoclasts were placed on
OCP-coated plates and further incubated for 24 h (c). The circled
solid lines indicate osteoclastic cells developing actin filaments
(arrows) on OCP. The circled dotted lines indicate osteoblastic
cells that are most likely present underneath other cells. The
actin filaments were labeled with rhodamine-conjugated phal-
loidin. The details of the experiments have been reported in
Takami et al. [31]. Bars = 100 mm (a and b) and 50 mm (c).
OCP-based bone substitute materials 63higher for OCP than HA [25]. These results suggest that the
degree of osteoclastic resorption of OCP may be associated
with the amount of new bone stimulated by OCP [82]. The
tissue formation shown in Fig. 2 included reactive bone
formation through the creation of the defect, which is usually
observed in the medullary site [23,46]. The reactive bone
formation resulted in enhanced remodeling of bone marrow
tissue accompanied by the complete resorption of OCP gran-
ules from the medullary site. However, in general, the OCP
granules remained mostly within the repaired cortical bone
encapsulated as debris (Fig. 3a and b). This may be one of the
characteristics of OCP biodegradation if used in long bone,
although the biodegradable properties of OCP through osteo-
clast-like cellular resorption appear to be the same when
implanted into intramembranous bone, such as calvaria bone
[25,81,82]. Therefore, OCP is a material that can be remo-
deled together with bone.
5. Phase conversion of OCP in vivo and in
vitro and the relation to tissue fluid
interaction
It has been reported that body fluids are almost saturated with
respect to the OCP phase from studies of calcium phosphate
solubilities [84] and the equilibrium of human serum [85]. X-
ray diffraction analysis confirmed that implanted OCP tends to
gradually convert to HA over time in various bone sites or
subcutaneous sites [19,30,75,86]. Furthermore, Fourier trans-
form infrared spectroscopy (FTIR) verified that the incubation
of OCP in medium also facilitates conversion to the HA phase
[30]. OCP conversion into the HA phase was accompanied by
calcium ion consumption into the crystals and inorganic phos-
phate (Pi) ion release from the crystals [59]. Although the
mechanism to promote OCP hydrolysis into HA has not been
fully characterized, it is conceivable that physiological fluids
include very small amount of fluoride ions [55], which is a
strong ionic promoter of OCP hydrolysis and works at very low
concentrations [87], in these physiological conditions. Circu-
lating serum proteins, such as a2HS-glycoproteins, can be
adsorbed by OCP in vivo [75]. The advancement of OCP
hydrolysis, which has been studied using OCP and its OCP
hydrolyzates as adsorbents, modulates the adsorption affinity
of bovine serum albumin [48]. Recent proteomic analyses
confirmed that OCP can adsorb over one hundred proteins
from rat serum [88]. In addition, proteins involved in bone
metabolism, such as apoliporoteins, were identified [88],
suggesting the possibility that the proteins adsorbed onto
OCP influence bone regeneration by OCP in vivo [88—91].
6. In vitro cellular response to OCP
When mouse bone marrow stromal ST-2 cells were cultured on
culture plates coated with OCP, the OCP significantly stimu-
lated the differentiation of ST-2 cells into osteoblastic cells to
a greater extent than HA [30]. The OCP-mediated differentia-
tion was enhanced in a dose-dependent manner, while HA did
not exhibit such an effect [20]. The mRNA expression of alka-
line phosphatase (ALP), osterix, and type I collagen was sig-
nificantly up-regulated by OCP in a dose-dependent manner
[20]. Another distinguishing characteristic regarding the cel-
lular response to OCP was the OCP-mediated enhancement ofosteoclast formation [31]. Osteoclast formation was examined
by co-culturing bone marrow cells (osteoclast precursor cells)
and osteoblastic cells in the absence of 1,25(OH)2D3 in the
culture media, which is an essential factor needed to up-
regulate the receptor activator of NF-kB ligand (RANKL)
expression in osteoblasts [31]. Fig. 4 shows the precise appear-
ance of TRAP-positive osteoclast-like cells on OCP coated
plates (Fig. 4a). When OCP was absent in the culture, TRAP-
positive cells did not form in the absence of 1,25(OH)2D3
(Fig. 4b). Moreover, the osteoblasts expressed RANKL, an
osteoclast differentiation factor, when incubated with OCP
[31]. These results demonstrated that OCP is capable of indu-
cing osteoclast formation by activating osteoblasts in vitro
[31]. In order to examine osteoclast attachment onto the OCP
surface, mature osteoclasts were formed from co-cultures in
the presence of 1,25(OH)2D3 and then placed onto OCP-coated
plates (Fig. 4c). Actin filament formation was observed in
64 O. Suzukiosteoclasts grown on OCP, indicating that osteoclasts are
relatively firmly attached onto the OCP surface. Together,
these results suggest that OCP is a material that stimulates
cells, and in particular osteoblastic cells, to enhance new bone
formation by osteoblasts and its own biodegradation by osteo-
clasts, which is advantageous in the physiological bone remo-
deling process [15].
7. Possible mechanism of OCP-stimulated
bone regeneration
One possible mechanism of OCP-stimulated bone regenera-
tion is summarized in Fig. 5, which is hypothesized based onFigure 5 Schematic view of bone formation by OCP-based in vivo obse
differentiation and osteoclast formation by OCP crystals based on in vitr
during a process of OCP—HA conversion. The up-regulation of osteoblast d
is induced by OCP crystals. Osteoclast formation is induced by co-culturin
absence of 1,25(OH)2D3. The up-regulation of RANKL in osteoblasts is indu
progressively but very slowly, and induces physicochemical changes, incl
well as elevated adsorption affinity of serum proteins, such as a2HS-glexperimental evidence. The biological responses of OCP
both in vitro and in vivo were compared with the OCP
hydrolyzate prepared by the hydrolysis of the original OCP
in hot water [30]. OCP hydolyzate had a Ca/P molar ratio
1.46 compared to the stoichiometric 1.67 of HA but showed
single HA phase in its structure. OCPhydrolyzate, namely Ca-
deficient HA, maintained the original plate-like OCP mor-
phology even after the hydrolysis. From these material
characteristics, Ca-deficient HA obtained via OCP, would
be a veritable control material to investigate as to how
OCP responds to osteoblastic cells or bone tissues [30].
OCP implanted in rat calvaria defect was progressively con-
verted to apatitic phase as observed previously in the
implantation onto mouse calvaria [19]. OCP enhanced thervations (a) and the possible mechanism for induction of osteoblastic
o experimental findings (b). Osteoblastic differentiation is enhanced
ifferentiation markers, such as alkaline phosphate (ALP) and osterix,
g the cells with osteoblastic cells and bone marrow cells even in the
ced by the OCP crystals. The process of OCP to HA conversion occurs
uding Ca2+ consumption and inorganic phosphate (Pi) ions release as
ycoproteins.
OCP-based bone substitute materials 65bone regeneration in rat calvaria defect significantly more
than OCP hydrolyzate did. OCP tended to enhance osteo-
blastic cell differentiation more than OCP hydrolyzate in vitro
[30]. The effect of which was confirmed later in quantitative
analysis of the expression of osteoblast differentiation markers
[20]. As explained in Fig. 1, bone formation by OCP granule
implantation is usually accompanied with bone matrix synth-
esis by osteoblasts and biodegradation of OCP by osteoclast-
like cells [23,25,30,38,46]. It is highly probable that the
osteoblasts that are attached onto the OCP granule surface
may be stimulated by each OCP crystal, which forms an
aggregate of the granules (Fig. 5a). Fig. 5b summarizes the
mechanism of OCP-stimulated bone formation. Bone marrow
stromal cells attach onto OCP crystals and proliferate [30,59],
and the OCP crystals enhance osteoblastic differentiation
[20,30]. Osteoclast formation from adjacent bone marrow
osteoclast precursor cells is also induced by osteoblasts due
to the OCP-induced up-regulation of RANKL [31]. These cel-
lular responses advance during the OCP conversion into HA
[20,30]. The conversion process induces physicochemical
alterations around the OCP crystals, including ionic exchanges
of Ca2+ and Pi ions [20,59], with the change of DS value, as well
as serum protein adsorption [48,92]. However, the osteocon-
ductivity of OCP is remarkably controlled by the stoichiometry
(a variety of chemical composition) of OCP [46] and the crystal
microstructure [81]. Non-stoichiometric OCP, having a Ca/P
molar ratio of 1.37, which is a slightly higher Ca/P molar ratio
compared to the stoichiometric 1.33 and a product generated
from the early stage of the OCP hydrolysis in an experimental
hot water incubation, significantly increases the osteoconduc-
tivity of the original OCP [30,46]. In contrast, the large OCP
crystals, which grow toward the long axis of the crystals,
markedly suppress the osteoconductivity of OCP [81].
8. OCP-based materials
There are two aspects to consider when preparing composite
materials with OCP: the moldability and increasing the
osteoconductivity of OCP [51,93,94]. OCP-based materials
developed to date have considered these aspects [51,93,94].
Due to the inclusion of a large number of water molecules in
the structure [18,95,96], the phase of OCP cannot be main-
tained during sintering, unlike HA or b-TCP ceramics. There-
fore, combining OCP with other materials, such as polymers,
are required to form larger three-dimensional implant
bodies. The second aspect to be considered is how well
the OCP crystals are dispersed within the matrix materials,
which may increase the number of sites available for bone
development initiation, resulting in enhancement of bone
regeneration [51,97]. Although several studies have shown
that OCP coating on titanium or titanium alloy raises the
osteoconductivity of the original metal surfaces [21,74,98—
102], the use of OCP-based composite materials is favorable
from the view point of the biodegradation coupled with new
bone formation, even in implants with a large volume used
for larger bone defects. In regard to the stability of OCP-
based materials, including the stability of the OCP crystal
itself, the characteristics of the materials can be maintained
as long as stored under drying condition and even after the
various sterilizations, such as electron beam irradiation
[20,47,75,103].8.1. OCP—gelatin composite
Composite materials composed of OCP and gelatin (Gel) mole-
cules have been recently developed through the co-precipita-
tion of OCP together with various concentrations of Gel
molecules [51]. Gel is a random coiled molecule that is derived
from denatured collagen [104]. Gel preserves a cellular attach-
ment motif [105], and reconstituted materials are extensively
used in biomedical applications [106], including scaffolds
[107,108]. Gel materials are known to be highly biodegradable
compared to collagen [104]. This is because collagen biode-
grades into telopeptides through decomposition to Gel mole-
cules [104]. OCP/Gel composites containing OCP up to 40 wt%
were obtained [51]. After cross-linking of the Gel matrix in the
composites through dehydrothermal treatment, the resulting
composite materials were highly porous and contained homo-
genously dispersed OCP [51]. The OCP crystals elongated toward
the long axis were found to be closely associated with the Gel
matrix [51]. Fig. 6a shows an example of an OCP/Gel composite
(40 wt% of OCP) molded as rod-like implants. Scanning electron
microscopy (SEM) showed that the OCP/Gel composite had pores
that were approximately 500 mm in diameter (Fig. 6b); however,
mercury intrusion porosimetry determined the pore size to be in
the range of 10—500 mm in diameter [51]. Importantly, a rat
calvaria critical-sized defect that was experimentally created
with a 9 mm diameter and not repaired spontaneously  was
sufficiently repaired by the implantation of the OCP/Gel com-
posite (40 wt% of OCP; 9 mm in diameter and 1 mm thick) after
16 weeks [51]. Fig. 6c shows the soft x-ray photograph with a
highly radiopacity within the defect corresponding to new bone
formation. Histomorphometric analysis revealed that the newly
formed bone area was estimated to be 71% of the defect area
[51], which is close to the value attained by autograft (85% of the
defect area) [109] or implantation of a chitosan gel composite
seeded with mesenchymal stem cells (MSCs) and bone morpho-
genetic proteins (BMP-2) (80% of the defect area) in similar
critical-sized calvaria defects [110]. Thus, the OCP/Gel compo-
site is a material that efficiently repairs intramembranous bone
defects [51]. The efficiency of the OCP/Gel composite for
repairing a long bone defect (4 mm diameter in rabbit tibia)
[97], which is frequently used as an orthopedic bone defect
model, was also assessed. Although the control group (defect
only) was not sufficiently bridged by the repaired bone (Fig. 6d),
the implantation of OCP/Gel (40 wt% of OCP; 4 mm in diameter
and 5 mm thick) induced new bone formation that was qualita-
tively better than the control group 2 weeks after the implanta-
tion into the defect (Fig. 6d and e). In addition, the OCP/Gel
composite appeared to almost completely biodegrade (Fig. 6e).
Based on these findings, it seems likely that the OCP/Gel
composite is a material that potentially has regenerative cap-
abilities that approach those of autologous bone.
8.2. OCP—collagen composite
Re-constituted collagen (Col) is also a cell-attaching matrix
protein, and therefore its spongy nature has been widely used
as scaffolding material, often in combination with calcium
phosphates [8,39,94,111—115]. Nano-HA crystals deposited
on self-assembled Col fibril-based HA/Col composites have
been developed as a bone tissue-mimicking material [39] that
displays excellent bone regenerative and biodegradable
Figure 6 Examples of bone regenerative properties of an OCP-based material consisting of OCP-precipitated gelatin (Gel) molecules
(OCP/Gel composite) in bone defects. (a) Rod-like OCP/Gel composites; (b) SEM observation of an OCP/Gel composite showing porous
characteristics; (c) soft X-ray photograph of rat critical-sized calvaria defects at 16 weeks after the implantation of an OCP/Gel disk
having a 9 mm diameter and 1 mm thickness, showing high radiopacity, indicating active bone regeneration; (d) control group (defect
only) and (e) experimental group (OCP/Gel implantation) of decalcified, H&E stained histological sections of an OCP/Gel composite
having a 4 mm diameter and 5 mm thickness, implanted in the intramedullary canal of a rabbit tibia at 2 weeks. The section shows
remarkable bone repair in the OCP/Gel implantation group (e) and markedly less bone formation in the control group. The details of the
experiments have been reported in Handa et al. [51] and Suzuki et al. [97]. The arrow (shown by a dotted line) in (c) indicates the
defect created before repair. Bars = 4 mm (a), 500 mm (b), 4 mm (c), and 3 mm (d and e). All procedures in the experiment were
approved by the Animal Research Committee of Tohoku University.
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repairing bone tissue has been previously reported for rabbit
long bone defects [113]. Recently, the effect of an OCP/Col
composite consisting of OCP granules, which have been
shown to have osteoconductive properties as described
above, and porcine dermis-derived atelo-Col, has been
assessed in intramembranous bone defects in the field of
oral surgery using critical-sized defects in different animal
models, such as rat and dog [94,103,116]. The disk-shaped
sponge of the OCP/Col (77 wt% of OCP) material enhanced
bone regeneration more than the OCP granules alone [94],
indicating the synergistic effect of the Col matrix, although
the disk of Col alone did not enhance bone formation [94].
The OCP/Col composite increased the bone regenerative
properties in an OCP dose-dependent manner from 23 wt%
to 83 wt% [117] and OCP granule size-dependent manner
from 53—300 mm to 500—1000 mm [83] in rat calvaria
defects. Moreover, the OCP/Col (77 wt% of OCP) composite
seeded next to rat bone marrow-derived MSCs further
enhanced bone regeneration in a rat calvaria defect [118].
In contrast, mechanical stress loaded onto the OCP/Col
material induced excessive osteoclastic resorption of its
own materials, resulting in a complete resorption of the
materials without bone regeneration [119]. However, alle-
viation of the mechanical stress using a stress-shielding
support material restored the bone regenerative propertyof OCP/Col [120]. Therefore, OCP/Col is a material that has
greater bone regenerative properties than OCP alone due to
the synergistic effect of the Col matrix.
8.3. OCP—alginate composite
Alginate (Alg) is well-recognized as a useful hydrogel mate-
rial for various cellular encapsulations because Alg molecules
do not provide cellular-attaching sites, unlike Gel and Col
molecules, and therefore the cells are not induced to differ-
entiate [121,122]. OCP/Alg composites were developed using
OCP-co-precipitated Alg molecules [93]. The pore size of the
composites ranging from 6 to 52 mm markedly affected in
vivo bone regeneration of mouse critical-sized calvaria
defects and in vitro osteoblastic cell attachment [93].
Although the effect of seeding stem cells with the OCP/Alg
composite has not been examined as yet, the effect of OCP
crystals in an Alg matrix, if combined with stem cells such as
MSCs, is of great interest in the tissue engineering field.
8.4. Characteristics of OCP-based materials
compared to calcium phosphate cement materials
The crystals of HA converted from the implanted OCP onto rat
calvaria in the form of OCP/Col composite have been
OCP-based bone substitute materials 67attributed to be a biomimetic carbonate-containing apatite
crystals [119]. Although the capability of OCP to form osteo-
clasts from the precursor cells on the surface [31] could be
the primary cause to enhance the biodegradation of OCP
[23], the formation of carbonated-HA from OCP in vivo may
strengthen the material replacement with newly formed
bone [8,42,43]. Various injectable and osteoconductive cal-
cium phosphate cements have been developed and reported
to be effective in enhancing bone formation if putting them
into bone defects [4,123,124]. A cement mixing tetracalcium
phosphate (TTCP) with DCPA can be hardened in vivo as
carbonated-HA, resulting in becoming to show the biodegrad-
able property [125]. Brushite-forming cements, originated
from b-TCP and monocalcium phosphate monohydrate
(MCPM) or phosphoric acid, are also recognized as osteocon-
ductive and biodegradable materials which are slowly con-
verted to carbonated-HA [126,127]. The calcium phosphate
cement materials that contain OCP phase in its composition
have also been developed from the mixture of a-TCP and
DCPA [128,129] or a-TCP, MCPM, calcium carbonate and
phosphate solution [130,131] as filling agents for the defects
in bone and tooth. Our previous studies suggest that the
biological activity of OCP is induced during a physicochemical
OCP—HA conversion process [19,30] in particular at the early
stage of the conversion in OCP [46]. However, further study is
required to elucidate the precise mechanism concerning the
osteoconductivity induced in the present OCP-based materi-
als in relation to the osteoconductivity observed in other
calcium phosphate cement materials.
9. Conclusion
It is clear that OCP exhibits a stimulatory effect on the
activity of osteoblasts during the conversion into HA in
physiological environments [20,30,31]. However, the osteo-
conductive properties of OCP crystals vary greatly depending
on the OCP preparations [49]. This may be due to variation in
the stoichiometry [46] and the crystal morphological features
[81] of OCPs that are obtained in the preparations, which
most likely occurs through controlled crystal growth and the
tendency for slight hydrolysis during the preparation based
on the condition used [19,26,132—135]. Although the osteo-
conductive property of OCP is highly dependent on such
physicochemical properties of the crystals that are obtained,
OCP-based materials, if prepared in well-controlled condi-
tions, could be good candidates for an advanced material
that approaches to autologous bone.
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